[1] ASHBY M,PETKOVA A,GANI J,et al. Use of peptide libraries for identification and optimization of novel antimicrobial peptides[J]. Curr Top Med Chem, 2017, 17(5):537-553. [2] WANG S, ZENG XF, YANG Q,et al. Antimicrobial peptides as potential alternatives to antibiotics in food animal industry[J]. Int J Mol Sci, 2016, 17(5):E603. [3] CIPE G,IDIZ U O,FIRAT D,et al. Relationship between intestinal microbiota and colorectal cancer[J]. World J Gastrointest Oncol, 2015, 7(10):233-240. [4] PIKTEL E,NIEMIROWICZ K,WNOROWSKA U,et al. The role of cathelicidin LL-37 in cancer development[J]. Arch Immunol Ther Exp (Warsz), 2016, 64(1):33-46. [5] OKAMOTO R, GERY S, KUWAYAMA Y,et al. Novel Gemini vitamin D3 analogs:large structure/function analysis and ability to induce antimicrobial peptide[J]. Int J Cancer, 2014, 134(1):207-217. [6] YANG Y H,ZHENG G G,LI G,et al. Expression of LL-37/hCAP-18 gene in human leukemia cells[J]. Leuk Res, 2003, 27(10):947-950. [7] REN S X,CHENG A S,TO K F,et al. Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer[J]. Cancer Res, 2012, 72(24):6512-6523. [8] KIM K H,LEE I S,PARK J Y,et al. Cucurbitacin B induces hypoglycemic effect in diabetic mice by regulation of AMP-activated protein kinase alpha and glucagon-like peptide-1 via bitter taste receptor signaling[J]. Front Pharmacol, 2018, 9:1071. DOI:10.3389/fphar.2018.01071. [9] KANG H K, KIM C, SEO C H,et al. The therapeutic applications of antimicrobial peptides (AMPs):a patent review[J]. J Microbiol, 2017, 55(1):1-12. [10] JI P,ZHOU Y X,YANG Y B,et al. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling[J]. Theranostics, 2019, 9(8):2209-2223. [11] ISLAM D,BANDHOLTZ L,NILSSON J,et al. Downregulation of bactericidal peptides in enteric infections:a novel immune escape mechanism with bacterial DNA as a potential regulator[J]. Nat Med, 2001, 7(2):180-185. [12] BERGMAN P,JOHANSSON L,ASP V,et al. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37[J]. Cell Microbiol, 2005, 7(7):1009-1017. [13] RAQIB R,SARKER P,BERGMAN P,et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic[J]. Proc Natl Acad Sci U S A, 2006, 103(24):9178-9183. [14] STEINMANN J,HALLDRSSON S,AGERBERTH B,et al. Phenylbutyrate induces antimicrobial peptide expression[J]. Antimicrob Agents Chemother, 2009, 53(12):5127-5133. [15] MILY A,REKHA R S,KAMAL S M,et al. Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages:a dose finding study for treatment of tuberculosis[J]. BMC Pulm Med, 2013, 13:23. DOI:10.1186/1471-2466-13-23. [16] YUK J M,SHIN D M,LEE H M,et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin[J]. Cell Host Microbe, 2009, 6(3):231-243. [17] REKHA R S, RAO MUVVA S S, WAN M, et al. Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages[J]. Autophagy, 2015,11(9):1688-1699. [18] 高旭峰,程先硕,周坦,等. 抗菌肽LL-37在结直肠癌中的研究进展[J]. 现代肿瘤医学, 2018, 26(9):1441-1444. [19] PIERZYNOWSKA K, GAFFKE L, PODLACHA M, et al. Mucopolysaccharidosis and autophagy:controversies on the contribution of the process to the pathogenesis and possible therapeutic applications[J/OL]. Neuromolecular Med, 2019. https://doi.org/10.1007/s12017-019-08559-1. [20] WANG Q, WEI S, ZHOU S,et al. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction[J/OL]. Immunol Cell Biol,2020,98(1):54-66. [21] RANEK M J, KOKKONEN-SIMON K M, CHEN A N, et al. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress[J]. Nature, 2019, 566(7743):264-269. [22] DITE T A, LING N X Y, SCOTT J W, et al. The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs[J]. Nat Commun, 2017, 8(1):571. [23] 刘帛岩,李松岩,张红亮,等.肿瘤细胞减灭术联合腹腔热灌注化疗对结肠癌与直肠癌腹膜转移的远期疗效比较[J].解放军医学杂志,2020,45(1):79-83. |